Research on Medicine, Health, Technology, and Social Overhead Capital
| Project/Area Number |
11630055
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
経済政策(含経済事情)
|
|---|
| Research Institution | KEIO UNIVERSITY |
|---|
Principal Investigator |
ANEGAWA Tomofumi Keio University, Graduate School of Business Administration, Professor., 大学院・経営管理研究科, 教授 (80159417)
|
|---|
| Project Period (FY) |
1999 – 2000
|
| Project Status |
Completed (Fiscal Year 2000)
|
| Budget Amount *help |
¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 2000: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1999: ¥1,000,000 (Direct Cost: ¥1,000,000)
|
|---|
| Keywords | health / medicine / technology / insurance / pharmaceutical / value / social overhead capital / 医療機器 / M&A / 公共政策 |
|---|
| Research Abstract |
This study investigates the relationship among health, medical system, technology, and social overhead capital. First this study examines how health of people of a nation is determined. Using data on the OECD countries, I found that life expectancy is not explained by per capita medical expenditure. On the other hand, I found that per capita consumption of pharmaceutical, hygiene, education level, and less tobacco consumption are shown to increase life expectancies.
Second, I attempt to estimate the value of health in a new method. I find that life time consumption and social overhead capital can be used to estimate the value of health.
Third, I examine the role of medical insurance on medical technology. I use the case of pharmaceutical industry. Japanese medical insurance has led pharmaceutical R＆D toward less innovative products.
Fourth, I analyze the international transfer of knowledge in medical technology. I use the pharmaceutical technology. By tracking patent data, I find that transfer of knowledge is limited within the same firm and nation.
|
Report
(3 results)
Research Products
(7 results)
